AEST.MED.INT.HLD.SP.ADR/3 Working Capital to Net Assets Ratio
AEST.MED.INT.HLD.SP.ADR/3 working capital to net assets ratio. AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Working Capital to Net Assets ratio of 680.4% as of December 2025. Working capital of €-294.15 Million (current assets of €134.40 Million minus current liabilities of €428.55 Million) is measured against net assets of €-43.23 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)
Working capital to net assets ratio of AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025. This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 680.4%, reflecting working capital of €-294.15 Million against net assets of €-43.23 Million EUR. Explore 3FMA long-term investment intensity to see how much of total assets are deployed in long-term investments.
AEST.MED.INT.HLD.SP.ADR/3 Working Capital to Net Assets Ratio by Year (2021–2025)
AEST.MED.INT.HLD.SP.ADR/3 working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 3FMA current and non-current assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 680.4% | €-294.15 Million | €-43.23 Million | €134.40 Million | €428.55 Million | ▲ +4039.6 pp |
| 2024 | -3359.3% | €-313.96 Million | €9.35 Million | €88.08 Million | €402.04 Million | ▼ -2467.7 pp |
| 2023 | -891.5% | €-299.81 Million | €33.63 Million | €111.57 Million | €411.38 Million | ▼ -1261.9 pp |
| 2022 | 370.4% | €-466.24 Million | €-125.88 Million | €77.60 Million | €543.84 Million | ▲ +140.8 pp |
| 2021 | 229.6% | €-427.95 Million | €-186.42 Million | €113.71 Million | €541.66 Million | — |